Denosumab 60 mg vs 120 mg: What the Prolia and Xgeva Labels and Trials Report
Denosumab 60 mg vs 120 mg is a comparison hospital pharmacies run into often, because the same medicine is stocked in two very different forms under two different brand names. The 60 mg product (sold as Prolia) and the 120 mg product (sold as Xgeva) contain the same antibody, yet their approved uses, labelled schedules […]
Copellor (Ixekizumab) India — What Hospitals and Dermatologists Need to Know
1. What Is Copellor (Ixekizumab)? Copellor® is the brand name for Ixekizumab, a humanised anti-interleukin-17A (anti-IL-17A) IgG4 monoclonal antibody manufactured by Eli Lilly and Company India Pvt Ltd and approved by the Drugs Controller General of India (DCGI). It is available as an 80mg/mL subcutaneous injection in a pre-filled syringe or auto-injector. Ixekizumab works by […]
Endoprost (Alprostadil) India — What Hospitals Need to Know
For hospital pharmacists, neonatologists, vascular surgeons, and urologists sourcing critical-care injectables in India, Endoprost (Alprostadil) is one of the most clinically important — and procurement-sensitive — medicines on any formulary. This guide covers what hospital procurement teams across India need to know about Alprostadil: what it is, which clinical departments depend on it, how it […]
How to Verify That Your Imported Cancer Medicine Is Genuine — A Safety Guide for Hospital Pharmacists in India 2026
In May 2026, Delhi Police busted a counterfeit medicine racket worth nearly Rs 10 crore — four people arrested for manufacturing and supplying fake life-saving drugs for cancer and liver disease. Fake medicines, packaging equipment, forged labels — all recovered from an operation supplying hospitals across multiple states. Weeks earlier in April 2026, a detailed […]
